Szemészet, 2014 (151. évfolyam, 1-4. szám)

2014-03-01 / 1. szám

Subretinalis vérzés műtéti megoldása

Irodalom

1. Baeteman C, Hoffart L, Galland fi et al. Subretinal hemorrhage after intravitreal injection of anti-VEGF for age-related macular degeneration: a retrospective study. J Fr Ophtalmol 2009; 32: 309-313.

2. Chen CY, Hooper C, Chiu D, et al. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas. Retina 2007; 27: 321-328.

3. Daneshvar H, Kertes PJ, Leonard BC, Peyman GA. Management of submacular hemorrhage with intravitreal sulfurhexafluoride: a pilot study. Can J Ophthalmol 1999; 34: 385-388.

4. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 1982; 94: 762-773.

5. Guthoff R, Guthoff T, Meigen T, et al. Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration. Retina 2011; 31(1): 36-40.

6. Hassan AS, Johnson MW, Schneiderman ТЕ, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 1999;106:1900-1906.

7. Haupert CL, McCuen BW, Jaffe GJ, et al. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in agerelated macular degeneration. Am J Ophthalmol 2001; 131: 208-215.

8. Hillenkamp J, Surguch V, Framme C, et al. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol 2010; 248: 5-11.

9. lacono R Parodi MB, Introini U, et al. Intravitreal ranibizumab for choroidal neovascularization with large submacular in age-related macular degeneration. Retina 2013 Jul 11. lEpub ahead of print)

10. Kamei M, Tano Y. Tissue plasminogen activator-assisted vitrectomy: surgical drainage of submacular hemorrhage. Dev Ophthalmol 2009; 44: 82-88.

11. Kapran Z, Ozkaya A, Uyar 0M. Hemorrhagic age-related macular degeneration managed with vitrectomy, subretinal injection of tissue plasminogen activator, gas tamponade, and upright positioning. Ophthalmic Surg Lasers Imaging Retina 2013; 44 (5): 471-6.

12. Kiernan DF Hariprasad SM, Rusu IM, et al. Epidemiology of the association between anticoagulants and intraocular hemorrhage in patients with neovascular age-related macular degeneration. Retina 2010; 30:1573-1578.

13. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 1994;118: 559-568.

14. Lumi X, Sulak M. Treatment of submacular haemorrhage in patients' with neovascular age related macular degeneration. Coll Antropol 2013 Apr; 37 (Suppl 1): 223-6.

15. Mayer WJ, Hakim I, Haritoglou C, et al. Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage. Acta Ophthalmol 2011 Sep 22. doi: 10.1111/j.1755-3768.2011.02264.x.

16. Meyer CH, Scholl HR Éter N, et al. Combined treatment of acute

subretinal hemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study. Acta Ophthalmol 2008; 86: 490-494.

17. Nayak S, Padhi TR, Basu S, Das T. Pneumatic Displacement and intravitreal Bevacizumab in Management of Sub-retinal and Sub-retinal Pigment Epithelial Hemorrhage at Macula in Polypoidal Choroidal Vasculopathy (PCV): Rationale and Outcome. Semin Ophthalmol 2013 Aug 15.

18. Ninomiya Y, Lewis JM, Hasegawa T, Tano Y. Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes. Am J Ophthalmol 1996 Nov; 122 (5): 613-21.

19. Olivier S, Chow DR, Packo KH, et al. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration. Ophthalmology 2004; 111 (6): 1201-8.

20. Papavasileiou E, Steel DH, Liazos E, et al. Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration. Retina 2013 Apr; 33(4): 846-53.

21. Peyman GA, Nelson NC, Jr, Alturki W, et al. Tissue plasminogen activating factor assisted removal of subretinal hemorrhage. Ophthalmic Surg 1991; 22: 575-582.

22. Ratanasukon M, Kittantong A. Results of intravitreal tissue plasminogen activator and expansile gas injection for submacular hemorrhage in Thais. Eye (Lond) 2005; 19: 1328-1332.

23. Shienbaum G, Garcia Filho CA, et al. Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy. Am J Ophthalmol 2013 Jun; 155 (6): 1009-13.

24. Stifter E, Michels S, Prager F et al. Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage. Am J Ophthalmol 2007; 144: 886-892.

25. Szurman R Subretinal surgery for massive hemorrhage Ophthalmologe. 2012 Jul; 109 (7): 657-64.

26. Takeuchi K, Kachi S, Iwata E, et al. Visual function 5 years or more after macular translocation surgery for myopic choroidal neovascularisation and age-related macular degeneration. Eye (Lond) 2012 Jan; 26 (1): 51-60.

27. Treumer F, Klatt C, Roider J, et al. Subretinal co-application of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular hemorrhage. Br J Ophthalmol 2010; 94: 48-53.

28. Yang PM, Kuo HK, Kao ML, et al. Pneumatic displacement of a dense submacular hemorrhage with or without tissue plasminogen activator. Chang Gung Med J 2005; 28 (12): 852-859.

29. van Zeeburg EJT, et al. Literature Review of Recombinant Tissue Plasminogen Activator Used for Recent-Onset Submacular Hemorrhage Displacement in Age-Related Macular Degeneration Ophthalmologica 2013; 229: 1-14.

30. Whiteley WN, Slot KB, Fernandes R et al. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies. Stroke 2012; 43 (11): 2904-9.

Levelezési

cím